Analyst rating updates for Krystal Biotech, including a buy rating from TD Cowen and a consensus rating from MarketBeat.
2 reports, 1 independent
Updated Aug 31
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst rating updates for Krystal Biotech, including a buy rating from TD Cowen and a consensus rating from MarketBeat.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Krystal Biotech, Inc.
biotechnology company
Nothing else this week.
-
MarketBeat
American personal finance blog
-
TD Cowen
American investment bank
-
Jefferies Financial Group
American financial services company
Related events
- Analyst firms Jefferies and TD Cowen upgraded their ratings for Forgent Power Solutions, Inc., while MarketBeat provided consensus data.
- MarketBeat reported a Moderate Buy consensus rating for Genelux, while Benchmark reissued a speculative buy rating, and an insider sold shares.
- TD Cowen increased its target price to $3.00, while Jefferies Financial Group was involved in a rating update for Plug Power, with MarketBeat aggregating the consensus data.
- TD Cowen upgraded Cabaletta Bio shares to strong-buy, while Jefferies reissued a buy rating, and MarketBeat provided consensus data.
- Jefferies Financial Group reissued a buy rating for Dassault Aviation, while MarketBeat aggregated the stock data.